Impact of Secretion-Active Osteoblast-Specific Factor 2 in Promoting Progression and Metastasis of Head and Neck Cancer
Treatment success of head and neck cancer (HNC) is still hampered by tumor relapse due to metastases. Our study aimed to identify biomarkers by exploiting transcriptomics profiles of patient-matched metastases, primary tumors, and normal tissue mucosa as well as the <i>TCGA</i> HNC cohor...
Main Authors: | Désirée Gül, Andrea Schweitzer, Aya Khamis, Shirley K. Knauer, Guo-Bin Ding, Laura Freudelsperger, Ioannis Karampinis, Sebastian Strieth, Jan Hagemann, Roland H. Stauber |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/9/2337 |
Similar Items
-
The Vitamin D Receptor–BIM Axis Overcomes Cisplatin Resistance in Head and Neck Cancer
by: Aya Khamis, et al.
Published: (2022-10-01) -
Exploiting Vitamin D Receptor and Its Ligands to Target Squamous Cell Carcinomas of the Head and Neck
by: Laura Koll, et al.
Published: (2023-02-01) -
The osteoblast in regulation of tumor cell dormancy and bone metastasis
by: Jennifer Zarrer, et al.
Published: (2024-04-01) -
Profiling Cisplatin Resistance in Head and Neck Cancer: A Critical Role of the VRAC Ion Channel for Chemoresistance
by: Svenja Siemer, et al.
Published: (2021-09-01) -
Human Papillomavirus 16 DNA Methylation Patterns and Investigation of Integration Status in Head and Neck Cancer Cases
by: Ioannis Zygouras, et al.
Published: (2023-09-01)